TAC1

TAC1 Full Name

tachykinin, precursor 1

TAC1 Introduction

One of the recurring challenges in neurobiology and drug discovery is identifying molecular targets that can coherently explain how sensory signals are translated into complex physiological and behavioral outcomes. TAC1 (tachykinin precursor 1) has gained increasing attention as a central player in this context. The TAC1 gene encodes the precursor protein preprotachykinin-1, which undergoes enzymatic processing to generate several active neuropeptides, including substance P and neurokinin A. These tachykinins are widely expressed across the central and peripheral nervous systems and are essential mediators of neurochemical communication. Crucially, the generation of these functional peptides depends on the activity of proprotein convertases such as PC1 and PC2. Experimental evidence shows that impairment of these enzymes leads to defective TAC1 peptide maturation, resulting in diminished neuropeptide availability and disrupted signaling. This processing dependency creates a key bottleneck in translational research, where peptide bioavailability—not just gene expression—determines functional outcomes.

Beyond its biochemical role, TAC1 exerts broad influence over neural circuit function and physiological regulation. TAC1-expressing neurons have been identified as important modulators of respiratory rhythm within the brainstem, particularly in the preBötzinger complex, a critical center for generating breathing patterns. Activation of these neurons enhances respiratory activity and has been shown to counteract suppressed breathing under conditions such as opioid exposure. In parallel, TAC1 is deeply involved in pain and emotional processing. In regions like the parabrachial nucleus, TAC1-positive neurons interact with other neuropeptide systems, including CGRP pathways, to fine-tune pain perception and associated behavioral responses. Moreover, in the nucleus accumbens, TAC1-related circuits contribute to the encoding of aversive stimuli and drive avoidance behaviors, highlighting its role in linking emotional states to action selection.

Clinically, TAC1 is associated with a wide range of disorders that reflect its diverse functional footprint. Aberrant signaling of substance P has been implicated in chronic inflammatory pain, neuropathic pain, and migraine, positioning TAC1 as a valuable target for analgesic development. At the same time, its involvement in limbic circuits suggests a role in psychiatric conditions such as anxiety, depression, and stress-related disorders. In respiratory medicine, TAC1 pathways are being explored for their potential to mitigate opioid-induced respiratory depression, a major limitation of current pain therapies. Despite this promise, targeting TAC1 remains complex due to its dependence on precise peptide processing and its context-specific roles across neural systems. A deeper understanding of TAC1 biology will therefore be essential for designing therapies that are both effective and selective.

Alternate Names for TAC1

TAC1; tachykinin, precursor 1; NK2; NPK; NKNA; TAC2; Hs.2563; protachykinin-1; PPT; substance K

• 1.Saidi M, et al.; Tachykinins Processing is Significantly Impaired in PC1 and PC2 Mutant Mouse Spinal Cord S9 Fractions. Neurochem Res. 2015, 40(11):2304-16.
  2.Rousseau JP, et al.; Medullary tachykinin precursor 1 neurons promote rhythmic breathing. Elife. 2023, 12:e85575.